Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLUTION filgotinib versus azathioprine plus corticosteroids in steroid-dependent ulcerative colitis
jRCTs031240498Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of filgotinib, azathioprine and corticosteroids in autoimmune colitis (2 arms), sponsored by Gilead Sciences. Primary endpoint: Proportion of patients who achieved steroid-free EBS remission at Week 52. Started Apr 2025; status: completed.
02
Drugs
filgotinibazathioprinecorticosteroids
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCTs031240498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240498.